Indication
Fibrocystic Breast Changes
2 clinical trials
2 products
Clinical trial
Window Trial of Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer (a BEAUTY Study*)Status: Recruiting, Estimated PCD: 2024-07-31
Product
AbemaciclibClinical trial
Targeted Prevention of Postpartum-Related Breast CancerStatus: Recruiting, Estimated PCD: 2026-01-30
Product
Aspirin